BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Malik JA, Ahmed S, Yaseen Z, Alanazi M, Alharby TN, Alshammari HA, Anwar S. Association of SARS-CoV-2 and Polypharmacy with Gut–Lung Axis: From Pathogenesis to Treatment. ACS Omega. [DOI: 10.1021/acsomega.2c02524] [Reference Citation Analysis]
2 Che Q, Luo T, Shi J, He Y, Xu D. Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier. Front Cell Infect Microbiol 2022;12:863779. [DOI: 10.3389/fcimb.2022.863779] [Reference Citation Analysis]
3 Elekhnawy E, Negm WA. The potential application of probiotics for the prevention and treatment of COVID-19. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00252-6] [Reference Citation Analysis]
4 Odun-ayo F, Reddy L. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022;13:35-59. [DOI: 10.3390/gastroent13010006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Liu Y, Kuang D, Li D, Yang J, Yan J, Xia Y, Zhang F, Cao H. Roles of the gut microbiota in severe SARS-CoV-2 infection. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep 2021;10:300-6. [PMID: 34813042 DOI: 10.1007/s13668-021-00375-z] [Reference Citation Analysis]
7 Baradaran Ghavami S, Pourhamzeh M, Farmani M, Raftar SKA, Shahrokh S, Shpichka A, Asadzadeh Aghdaei H, Hakemi-Vala M, Hossein-Khannazer N, Timashev P, Vosough M. Cross-talk between immune system and microbiota in COVID-19. Expert Rev Gastroenterol Hepatol 2021;15:1281-94. [PMID: 34654347 DOI: 10.1080/17474124.2021.1991311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Prescott SL. A world of inflammation: the need for ecological solutions that co-benefit people, place and planet. Vet Dermatol 2021;32:539-e149. [PMID: 34415086 DOI: 10.1111/vde.13013] [Reference Citation Analysis]
9 Delgado-Gonzalez P, Gonzalez-Villarreal CA, Roacho-Perez JA, Quiroz-Reyes AG, Islas JF, Delgado-Gallegos JL, Arellanos-Soto D, Galan-Huerta KA, Garza-Treviño EN. Inflammatory effect on the gastrointestinal system associated with COVID-19. World J Gastroenterol 2021; 27(26): 4160-4171 [PMID: 34326616 DOI: 10.3748/wjg.v27.i26.4160] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Marcialis MA, Bardanzellu F, Fanos V. Microbiota and Coronavirus Disease 2019. Which Came First, the Chicken or the Egg? Clin Infect Dis 2021;72:2245-6. [PMID: 32645713 DOI: 10.1093/cid/ciaa965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lazar V, Ancuta P. SARS-CoV-2 - SYNOPTIC CHART OF THE MAIN CHARACTERISTICS OF VIRUS, PATHOGENESIS, IMMUNE RESPONSE, IMMUNOPROPHYLAXIS. Roum Arch Microbiol Immunol 2021;80:51-80. [DOI: 10.54044/rami.2021.01.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vaziri F. Comment on Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles. ACS Nano 2020;14:12265. [PMID: 33120503 DOI: 10.1021/acsnano.0c04871] [Reference Citation Analysis]
13 Kalantar-Zadeh K. Response to Comment on Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection. ACS Nano 2020;14:12266. [PMID: 33120507 DOI: 10.1021/acsnano.0c05759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 [DOI: 10.1101/2020.09.07.20189621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 [DOI: 10.1101/2020.04.25.060947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]